Global Medicine for Osteoarthritis Pain Market Research Report 2020

Global Medicine for Osteoarthritis Pain Market Research Report 2020

Table of Contents
1 Medicine for Osteoarthritis Pain Market Overview
1.1 Product Overview and Scope of Medicine for Osteoarthritis Pain
1.2 Medicine for Osteoarthritis Pain Segment by Type
1.2.1 Global Medicine for Osteoarthritis Pain Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Medicine for Osteoarthritis Pain Segment by Application
1.3.1 Medicine for Osteoarthritis Pain Sales Comparison by Application: 2020 VS 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Medicine for Osteoarthritis Pain Market Size Estimates and Forecasts
1.4.1 Global Medicine for Osteoarthritis Pain Revenue 2015-2026
1.4.2 Global Medicine for Osteoarthritis Pain Sales 2015-2026
1.4.3 Medicine for Osteoarthritis Pain Market Size by Region: 2020 Versus 2026
2 Global Medicine for Osteoarthritis Pain Market Competition by Manufacturers
2.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers (2015-2020)
2.2 Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers (2015-2020)
2.3 Global Medicine for Osteoarthritis Pain Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Medicine for Osteoarthritis Pain Manufacturing Sites, Area Served, Product Type
2.5 Medicine for Osteoarthritis Pain Market Competitive Situation and Trends
2.5.1 Medicine for Osteoarthritis Pain Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Medicine for Osteoarthritis Pain Players (Opinion Leaders)
3 Medicine for Osteoarthritis Pain Retrospective Market Scenario by Region
3.1 Global Medicine for Osteoarthritis Pain Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Medicine for Osteoarthritis Pain Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.3.1 North America Medicine for Osteoarthritis Pain Sales by Country
3.3.2 North America Medicine for Osteoarthritis Pain Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.4.1 Europe Medicine for Osteoarthritis Pain Sales by Country
3.4.2 Europe Medicine for Osteoarthritis Pain Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Medicine for Osteoarthritis Pain Market Facts & Figures by Region
3.5.1 Asia Pacific Medicine for Osteoarthritis Pain Sales by Region
3.5.2 Asia Pacific Medicine for Osteoarthritis Pain Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.6.1 Latin America Medicine for Osteoarthritis Pain Sales by Country
3.6.2 Latin America Medicine for Osteoarthritis Pain Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.7.1 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country
3.7.2 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Medicine for Osteoarthritis Pain Historic Market Analysis by Type
4.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2015-2020)
4.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Type (2015-2020)
4.3 Global Medicine for Osteoarthritis Pain Price Market Share by Type (2015-2020)
4.4 Global Medicine for Osteoarthritis Pain Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Medicine for Osteoarthritis Pain Historic Market Analysis by Application
5.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2015-2020)
5.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2015-2020)
5.3 Global Medicine for Osteoarthritis Pain Price by Application (2015-2020)
6 Company Profiles and Key Figures in Medicine for Osteoarthritis Pain Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Medicine for Osteoarthritis Pain Production Sites and Area Served
6.2.2 Johnson and Johnson Description, Business Overview and Total Revenue
6.2.3 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Johnson and Johnson Products Offered
6.2.5 Johnson and Johnson Recent Development
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Medicine for Osteoarthritis Pain Production Sites and Area Served
6.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.3.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GlaxoSmithKline Products Offered
6.3.5 GlaxoSmithKline Recent Development
6.4 Bayer
6.4.1 Bayer Medicine for Osteoarthritis Pain Production Sites and Area Served
6.4.2 Bayer Description, Business Overview and Total Revenue
6.4.3 Bayer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bayer Products Offered
6.4.5 Bayer Recent Development
6.5 Eli Lilly
6.5.1 Eli Lilly Medicine for Osteoarthritis Pain Production Sites and Area Served
6.5.2 Eli Lilly Description, Business Overview and Total Revenue
6.5.3 Eli Lilly Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Eli Lilly Products Offered
6.5.5 Eli Lilly Recent Development
6.6 Novartis
6.6.1 Novartis Medicine for Osteoarthritis Pain Production Sites and Area Served
6.6.2 Novartis Description, Business Overview and Total Revenue
6.6.3 Novartis Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Novartis Products Offered
6.6.5 Novartis Recent Development
6.7 Sanofi
6.6.1 Sanofi Medicine for Osteoarthritis Pain Production Sites and Area Served
6.6.2 Sanofi Description, Business Overview and Total Revenue
6.6.3 Sanofi Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.7.5 Sanofi Recent Development
6.8 Horizon Pharma
6.8.1 Horizon Pharma Medicine for Osteoarthritis Pain Production Sites and Area Served
6.8.2 Horizon Pharma Description, Business Overview and Total Revenue
6.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Horizon Pharma Products Offered
6.8.5 Horizon Pharma Recent Development
6.9 Abbott
6.9.1 Abbott Medicine for Osteoarthritis Pain Production Sites and Area Served
6.9.2 Abbott Description, Business Overview and Total Revenue
6.9.3 Abbott Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Abbott Products Offered
6.9.5 Abbott Recent Development
6.10 Mylan
6.10.1 Mylan Medicine for Osteoarthritis Pain Production Sites and Area Served
6.10.2 Mylan Description, Business Overview and Total Revenue
6.10.3 Mylan Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Mylan Products Offered
6.10.5 Mylan Recent Development
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Medicine for Osteoarthritis Pain Production Sites and Area Served
6.11.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Daiichi Sankyo Products Offered
6.11.5 Daiichi Sankyo Recent Development
6.12 TEVA
6.12.1 TEVA Medicine for Osteoarthritis Pain Production Sites and Area Served
6.12.2 TEVA Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.12.3 TEVA Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.12.4 TEVA Products Offered
6.12.5 TEVA Recent Development
6.13 Almatica Pharma
6.13.1 Almatica Pharma Medicine for Osteoarthritis Pain Production Sites and Area Served
6.13.2 Almatica Pharma Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.13.3 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Almatica Pharma Products Offered
6.13.5 Almatica Pharma Recent Development
6.14 Astellas Pharma
6.14.1 Astellas Pharma Medicine for Osteoarthritis Pain Production Sites and Area Served
6.14.2 Astellas Pharma Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.14.3 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Astellas Pharma Products Offered
6.14.5 Astellas Pharma Recent Development
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Medicine for Osteoarthritis Pain Production Sites and Area Served
6.15.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.15.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Tide Pharmaceutical Products Offered
6.15.5 Tide Pharmaceutical Recent Development
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Production Sites and Area Served
6.16.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.16.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Iroko Pharmaceuticals Products Offered
6.16.5 Iroko Pharmaceuticals Recent Development
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Production Sites and Area Served
6.17.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.17.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Hengrui Pharmaceutical Products Offered
6.17.5 Hengrui Pharmaceutical Recent Development
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Medicine for Osteoarthritis Pain Production Sites and Area Served
6.18.2 Abiogen Pharma Medicine for Osteoarthritis Pain Description, Business Overview and Total Revenue
6.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Abiogen Pharma Products Offered
6.18.5 Abiogen Pharma Recent Development
7 Medicine for Osteoarthritis Pain Manufacturing Cost Analysis
7.1 Medicine for Osteoarthritis Pain Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Medicine for Osteoarthritis Pain
7.4 Medicine for Osteoarthritis Pain Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Medicine for Osteoarthritis Pain Distributors List
8.3 Medicine for Osteoarthritis Pain Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Medicine for Osteoarthritis Pain Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Medicine for Osteoarthritis Pain by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Medicine for Osteoarthritis Pain by Type (2021-2026)
10.2 Medicine for Osteoarthritis Pain Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Medicine for Osteoarthritis Pain by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Medicine for Osteoarthritis Pain by Application (2021-2026)
10.3 Medicine for Osteoarthritis Pain Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Medicine for Osteoarthritis Pain by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Medicine for Osteoarthritis Pain by Region (2021-2026)
10.4 North America Medicine for Osteoarthritis Pain Estimates and Projections (2021-2026)
10.5 Europe Medicine for Osteoarthritis Pain Estimates and Projections (2021-2026)
10.6 Asia Pacific Medicine for Osteoarthritis Pain Estimates and Projections (2021-2026)
10.7 Latin America Medicine for Osteoarthritis Pain Estimates and Projections (2021-2026)
10.8 Middle East and Africa Medicine for Osteoarthritis Pain Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Medicine for Osteoarthritis Pain Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Medicine for Osteoarthritis Pain Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Medicine for Osteoarthritis Pain Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Medicine for Osteoarthritis Pain Manufacturers Covered in This Study
Table 5. Global Medicine for Osteoarthritis Pain Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Medicine for Osteoarthritis Pain Sales Share by Manufacturers (2015-2020)
Table 7. Global Medicine for Osteoarthritis Pain Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Medicine for Osteoarthritis Pain Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Medicine for Osteoarthritis Pain Sales Sites and Area Served
Table 11. Manufacturers Medicine for Osteoarthritis Pain Product Types
Table 12. Global Medicine for Osteoarthritis Pain Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Medicine for Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medicine for Osteoarthritis Pain as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Medicine for Osteoarthritis Pain Players
Table 16. Global Medicine for Osteoarthritis Pain Sales (K Units) by Region (2015-2020)
Table 17. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2015-2020)
Table 18. Global Medicine for Osteoarthritis Pain Revenue (Million US$) by Region (2015-2020)
Table 19. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region (2015-2020)
Table 20. North America Medicine for Osteoarthritis Pain Sales by Country (2015-2020) (K Units)
Table 21. North America Medicine for Osteoarthritis Pain Sales Market Share by Country (2015-2020)
Table 22. North America Medicine for Osteoarthritis Pain Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2015-2020)
Table 24. Europe Medicine for Osteoarthritis Pain Sales by Country (2015-2020) (K Units)
Table 25. Europe Medicine for Osteoarthritis Pain Sales Market Share by Country (2015-2020)
Table 26. Europe Medicine for Osteoarthritis Pain Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Medicine for Osteoarthritis Pain Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Medicine for Osteoarthritis Pain Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Medicine for Osteoarthritis Pain Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Medicine for Osteoarthritis Pain Revenue Market Share by Region (2015-2020)
Table 32. Latin America Medicine for Osteoarthritis Pain Sales by Country (2015-2020) (K Units)
Table 33. Latin America Medicine for Osteoarthritis Pain Sales Market Share by Country (2015-2020)
Table 34. Latin America Medicine for Osteoarthritis Pain Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Medicine for Osteoarthritis Pain Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Medicine for Osteoarthritis Pain Revenue Market Share by Country (2015-2020)
Table 40. Global Medicine for Osteoarthritis Pain Sales (K Units) by Type (2015-2020)
Table 41. Global Medicine for Osteoarthritis Pain Sales Share by Type (2015-2020)
Table 42. Global Medicine for Osteoarthritis Pain Revenue (Million US$) by Type (2015-2020)
Table 43. Global Medicine for Osteoarthritis Pain Revenue Share by Type (2015-2020)
Table 44. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Type (2015-2020)
Table 45. Global Medicine for Osteoarthritis Pain Sales (K Units) by Application (2015-2020)
Table 46. Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2015-2020)
Table 47. Global Medicine for Osteoarthritis Pain Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Medicine for Osteoarthritis Pain Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Johnson and Johnson Medicine for Osteoarthritis Pain Corporation Information
Table 54. Johnson and Johnson Corporation Information
Table 55. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Johnson and Johnson Main Product
Table 57. Johnson and Johnson Recent Development
Table 58. GlaxoSmithKline Medicine for Osteoarthritis Pain Corporation Information
Table 59. GlaxoSmithKline Corporation Information
Table 60. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. GlaxoSmithKline Main Product
Table 62. GlaxoSmithKline Recent Development
Table 63. Bayer Medicine for Osteoarthritis Pain Corporation Information
Table 64. Bayer Corporation Information
Table 65. Bayer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Bayer Main Product
Table 67. Bayer Recent Development
Table 68. Eli Lilly Medicine for Osteoarthritis Pain Corporation Information
Table 69. Eli Lilly Corporation Information
Table 70. Eli Lilly Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Eli Lilly Main Product
Table 72. Eli Lilly Recent Development
Table 73. Novartis Medicine for Osteoarthritis Pain Corporation Information
Table 74. Novartis Corporation Information
Table 75. Novartis Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Novartis Main Product
Table 77. Novartis Recent Development
Table 78. Sanofi Medicine for Osteoarthritis Pain Corporation Information
Table 79. Sanofi Corporation Information
Table 80. Sanofi Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Sanofi Main Product
Table 82. Sanofi Recent Development
Table 83. Horizon Pharma Medicine for Osteoarthritis Pain Corporation Information
Table 84. Horizon Pharma Corporation Information
Table 85. Horizon Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Horizon Pharma Main Product
Table 87. Horizon Pharma Recent Development
Table 88. Abbott Medicine for Osteoarthritis Pain Corporation Information
Table 89. Abbott Corporation Information
Table 90. Abbott Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Abbott Main Product
Table 92. Abbott Recent Development
Table 93. Mylan Medicine for Osteoarthritis Pain Corporation Information
Table 94. Mylan Corporation Information
Table 95. Mylan Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Mylan Main Product
Table 97. Mylan Recent Development
Table 98. Daiichi Sankyo Medicine for Osteoarthritis Pain Corporation Information
Table 99. Daiichi Sankyo Corporation Information
Table 100. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Daiichi Sankyo Main Product
Table 102. Daiichi Sankyo Recent Development
Table 103. TEVA Medicine for Osteoarthritis Pain Corporation Information
Table 104. TEVA Corporation Information
Table 105. TEVA Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. TEVA Main Product
Table 107. TEVA Recent Development
Table 108. Almatica Pharma Medicine for Osteoarthritis Pain Corporation Information
Table 109. Almatica Pharma Corporation Information
Table 110. Almatica Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Almatica Pharma Main Product
Table 112. Almatica Pharma Recent Development
Table 113. Astellas Pharma Medicine for Osteoarthritis Pain Corporation Information
Table 114. Astellas Pharma Corporation Information
Table 115. Astellas Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Astellas Pharma Main Product
Table 117. Astellas Pharma Recent Development
Table 118. Tide Pharmaceutical Medicine for Osteoarthritis Pain Corporation Information
Table 119. Tide Pharmaceutical Corporation Information
Table 120. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Tide Pharmaceutical Main Product
Table 122. Tide Pharmaceutical Recent Development
Table 123. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Corporation Information
Table 124. Iroko Pharmaceuticals Corporation Information
Table 125. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Iroko Pharmaceuticals Main Product
Table 127. Iroko Pharmaceuticals Recent Development
Table 128. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Corporation Information
Table 129. Hengrui Pharmaceutical Corporation Information
Table 130. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Hengrui Pharmaceutical Main Product
Table 132. Hengrui Pharmaceutical Recent Development
Table 133. Abiogen Pharma Medicine for Osteoarthritis Pain Corporation Information
Table 134. Abiogen Pharma Corporation Information
Table 135. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Abiogen Pharma Main Product
Table 137. Abiogen Pharma Recent Development
Table 138. Sales Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Medicine for Osteoarthritis Pain Distributors List
Table 141. Medicine for Osteoarthritis Pain Customers List
Table 142. Market Key Trends
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Global Medicine for Osteoarthritis Pain Sales (K Units) Forecast by Type (2021-2026)
Table 146. Global Medicine for Osteoarthritis Pain Sales Market Share Forecast by Type (2021-2026)
Table 147. Global Medicine for Osteoarthritis Pain Revenue (Million US$) Forecast by Type (2021-2026)
Table 148. Global Medicine for Osteoarthritis Pain Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 149. Global Medicine for Osteoarthritis Pain Sales (K Units) Forecast by Application (2021-2026)
Table 150. Global Medicine for Osteoarthritis Pain Revenue (Million US$) Forecast by Application (2021-2026)
Table 151. Global Medicine for Osteoarthritis Pain Sales (K Units) Forecast by Region (2021-2026)
Table 152. Global Medicine for Osteoarthritis Pain Sales Market Share Forecast by Region (2021-2026)
Table 153. Global Medicine for Osteoarthritis Pain Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Global Medicine for Osteoarthritis Pain Revenue Market Share Forecast by Region (2021-2026)
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Medicine for Osteoarthritis Pain
Figure 2. Global Medicine for Osteoarthritis Pain Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Medicine for Osteoarthritis Pain Consumption Market Share by Application: 2020 VS 2026
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Global Medicine for Osteoarthritis Pain Market Size 2015-2026 (US$ Million)
Figure 10. Global Medicine for Osteoarthritis Pain Sales Capacity (K Units) (2015-2026)
Figure 11. Global Medicine for Osteoarthritis Pain Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Medicine for Osteoarthritis Pain Sales Share by Manufacturers in 2020
Figure 13. Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Medicine for Osteoarthritis Pain Revenue in 2019
Figure 15. Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2015-2020)
Figure 17. Global Medicine for Osteoarthritis Pain Sales Market Share by Region in 2019
Figure 18. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region (2015-2020)
Figure 19. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region in 2019
Figure 20. North America Medicine for Osteoarthritis Pain Sales Market Share by Country in 2019
Figure 21. North America Medicine for Osteoarthritis Pain Revenue Market Share by Country in 2019
Figure 22. U.S. Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Medicine for Osteoarthritis Pain Sales Market Share by Country in 2019
Figure 27. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Country in 2019
Figure 28. Germany Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Medicine for Osteoarthritis Pain Sales Market Share by Region in 2019
Figure 39. Asia Pacific Medicine for Osteoarthritis Pain Revenue Market Share by Region in 2019
Figure 40. China Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Medicine for Osteoarthritis Pain Sales Market Share by Country in 2019
Figure 63. Latin America Medicine for Osteoarthritis Pain Revenue Market Share by Country in 2019
Figure 64. Mexico Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Medicine for Osteoarthritis Pain Revenue Market Share by Country in 2019
Figure 72. Turkey Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Medicine for Osteoarthritis Pain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Medicine for Osteoarthritis Pain Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Medicine for Osteoarthritis Pain Revenue

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs